缺血
再灌注损伤
肾
化学
急性肾损伤
肾缺血
药理学
心脏病学
医学
内科学
作者
Hao Wang,Junsong Guo,Xuefeng Ding,Ying Lü,Hao Xu,Xinyi Tian,Xin Tan,You Liao,Haiyang Jiang,Jing Wei,Haijun Peng,Zhanjun Gu,Hua-Yuan Yang,Houxiang Hu
标识
DOI:10.1016/j.cej.2024.150127
摘要
'. Renal ischemia–reperfusion injury (RIRI) is the main cause of acute kidney injury (AKI) and is associated with a poor prognosis. Current treatment options for AKI have limitations, highlighting the necessity for developing new treatments. Reactive oxygen species (ROS) play a pivotal role in the pathogenesis of RIRI-induced AKI. Therefore, fullerenol with ROS quenching properties may have the potential to treat RIRI-induced AKI. This study is the first time to investigate the potential protective effects of fullerenol nanoparticles against RIRI. In cell experiments, fullerenol can effectively mitigate HK-2 cell damage induced by hypoxia-reoxygenation through scavenging ROS and inhibiting apoptosis. In animal experiments, fullerenol is rapidly distributed to the liver and kidneys after entering the body and part of the fullerenol is slowly excreted through urine. Fullerenol accumulated in the kidney alleviates ischemia–reperfusion-induced kidney damage by inhibiting pro-apoptotic proteins and promoting the expression of anti-apoptotic proteins. These findings suggest that fullerenol nanoparticles have potential as drugs to prevent and treat RIRI.
科研通智能强力驱动
Strongly Powered by AbleSci AI